The nation of Zimbabwe has turned down a substantial American health deal valued at $367m (272 million pounds) spanning five years because of Washington's insistence on confidential biological samples.
This rejection came to light after a internal memorandum from December was leaked, revealing that President Emmerson Mnangagwa deemed the agreement was "skewed".
A government spokesman has since stated that the United States was requesting biological samples for scientific study and commercial gain but was unwilling to share the benefits from any future treatments.
"We must now begin the difficult and regrettable process of scaling back our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had furnished over $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has urged more dialogue to find a agreement agreeable to all parties so the nation's critical HIV programme can continue.
Broader Context
This rejection comes after a comparable case in Kenya, where a high court blocked a related health funding agreement after concerns were filed about the safety of citizens' health data.
Since returning to office last year, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
The agency had administered assistance for the US government, but Trump argued its spending was "inefficient" and his administration was seeking government-to-government deals to boost transparency and accountability.
According to statements, 16 African countries have so far agreed to these new agreements, constituting more than $18.3bn in committed funds.
Details of the Rejected Deal
The funds for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this collaboration could have provided extraordinary advantages for Zimbabwean communities, especially the 1.2 million presently on HIV treatment via American-funded programmes," the Ambassador added.
However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".
"Zimbabwe was being asked to share its genetic material and health information indefinitely, with no equivalent assurance of benefiting from any medical innovations – like new medicines or tests – that might result from that provided information," his statement read.
"Put simply, our nation would supply the basic resources for medical research without any certainty that the final treatments would be available to our population if a new health crisis emerge."
Sovereignty and Global Health
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were upending frameworks previously established through the global organization.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme created to manage potential pandemics.
"This framework is designed to ensure that when a nation contributes its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the resources to create them."
These objections regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We welcome ongoing dialogue with our US partners on how subsequent collaboration could be structured in a manner that honours the sovereignty and interests of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the government's concerns, but urged that talks must proceed considering much of the country's Aids initiatives were funded by international support.
"In cases where technical issues arise, such as those involving data governance or agreement terms, these can often be addressed via technical clarification and negotiated safeguards," it commented.
The situation highlights the ongoing debate between accepting crucial foreign assistance and protecting national sovereignty in an increasingly interconnected world.